{"related:dHlmBhRVIM0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders","url":"https://journals.lww.com/transplantjournal/fulltext/1999/11270/epstein_barr_virus_induced_posttransplant.15.aspx","authors":["CV Paya","CV Paya JJ Fung","CV Paya JJ Fung MA Nalesnik","CV Paya JJ Fung MA Nalesnik E Kieff","CV Paya JJ Fung MA Nalesnik E Kieff M Green…"],"year":1999,"numCitations":538,"pdf":"http://www.academia.edu/download/47681028/ASTSASTP_EBV-PTLD_Task_Force_and_The_May20160731-8928-9r2jof.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14780907521525053812&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dHlmBhRVIM0J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14780907521525053812&hl=en&as_sdt=0,5","publication":"journals.lww.com","p":1,"exp":1596370803398},{"title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult …","url":"https://journals.lww.com/transplantjournal/Fulltext/2001/04270/REDUCTION_IN_IMMUNOSUPPRESSION_AS_INITIAL_THERAPY.12.aspx","authors":["DE Tsai","DE Tsai CL Hardy","DE Tsai CL Hardy JE Tomaszewski","DE Tsai CL Hardy JE Tomaszewski RM Kotloff…"],"year":2001,"numCitations":382,"citationUrl":"http://scholar.google.com/scholar?cites=9378877306341740035&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:A854_Dd3KIIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9378877306341740035&hl=en&as_sdt=0,5","publication":"journals.lww.com"},{"title":"PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1","url":"https://journals.lww.com/transplantjournal/Fulltext/1998/12270/PREVENTION_AND_PREEMPTIVE_THERAPY_OF.6.aspx","authors":["SV McDiarmid","SV McDiarmid S Jordan","SV McDiarmid S Jordan GS Lee","SV McDiarmid S Jordan GS Lee M Toyoda…"],"year":1998,"numCitations":336,"citationUrl":"http://scholar.google.com/scholar?cites=15346508602841703977&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:KSbb1kPA-dQJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15346508602841703977&hl=en&as_sdt=0,5","publication":"journals.lww.com"},{"title":"Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients","url":"https://www.sciencedirect.com/science/article/pii/S0923753419576050","authors":["N Milpied","N Milpied B Vasseur","N Milpied B Vasseur N Parquet","N Milpied B Vasseur N Parquet JL Garnier…"],"year":2000,"numCitations":411,"pdf":"https://www.sciencedirect.com/science/article/pii/S0923753419576050/pdf?md5=7e2b3670d9bfa6377b94dc7c1203c51d&pid=1-s2.0-S0923753419576050-main.pdf","citationUrl":"http://scholar.google.com/scholar?cites=12274980439405146885&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BbOci6x9WaoJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12274980439405146885&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"INTERFERON-α TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1","url":"https://journals.lww.com/transplantjournal/Fulltext/1998/12270/INTERFERON___TREATMENT_OF_POSTTRANSPLANT.35.aspx","authors":["CL Davis","CL Davis BL Wood","CL Davis BL Wood DE Sabath","CL Davis BL Wood DE Sabath JS Joseph…"],"year":1998,"numCitations":140,"citationUrl":"http://scholar.google.com/scholar?cites=10782340581864373405&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nfxNxaGRopUJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10782340581864373405&hl=en&as_sdt=0,5","publication":"journals.lww.com"},{"title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","url":"https://academic.oup.com/cid/article-abstract/20/5/1346/414143","authors":["RC Walker","RC Walker WF Marshall","RC Walker WF Marshall JG Strickler…"],"year":1995,"numCitations":384,"citationUrl":"http://scholar.google.com/scholar?cites=1870070818420468160&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wKnGVIDT8xkJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1870070818420468160&hl=en&as_sdt=0,5","publication":"academic.oup.com"},{"title":"Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.","url":"https://www.ncbi.nlm.nih.gov/pubmed/9044505","authors":["NL Harris","NL Harris JA Ferry","NL Harris JA Ferry SH Swerdlow"],"year":1997,"numCitations":413,"citationUrl":"http://scholar.google.com/scholar?cites=15721380220187577256&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:qAsiywOQLdoJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15721380220187577256&hl=en&as_sdt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the …","url":"https://ashpublications.org/blood/article-abstract/84/3/972/49537","authors":["SA Riddler","SA Riddler MC Breinig","SA Riddler MC Breinig JL McKnight"],"year":1994,"numCitations":359,"citationUrl":"http://scholar.google.com/scholar?cites=7030421251941227403&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:i1tQP-ESkWEJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7030421251941227403&hl=en&as_sdt=0,5","publication":"ashpublications.org"},{"title":"Anti–B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome","url":"https://ashpublications.org/blood/article-abstract/92/9/3137/125739","authors":["M Benkerrou","M Benkerrou JP Jais","M Benkerrou JP Jais V Leblond…"],"year":1998,"numCitations":293,"pdf":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.968.8690&rep=rep1&type=pdf","citationUrl":"http://scholar.google.com/scholar?cites=388390530875475051&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:a0T1SiHXYwUJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=388390530875475051&hl=en&as_sdt=0,5","publication":"ashpublications.org"},{"title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","url":"https://academic.oup.com/jid/article-abstract/176/6/1462/807234","authors":["R Mañez","R Mañez MC Breinig","R Mañez MC Breinig P Linden","R Mañez MC Breinig P Linden J Wilson…"],"year":1997,"numCitations":267,"pdf":"https://academic.oup.com/jid/article-pdf/176/6/1462/2414803/176-6-1462.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14963103618972346866&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:8mk1qnafp88J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14963103618972346866&hl=en&as_sdt=0,5","publication":"academic.oup.com"}]}